Member Info for Mozax

So fast, as the freefloat continues to tighten.

We could break 10p today, imo.

Back today.

Moving up nicely.

You particularly.

From now on.

I haven’t ‘Heard’ or evidenced by regulatory TR1’s that Johnson, Akers or Duff are ‘offloading’.

In fact, quite the opposite.

Robert & Emma Johnson further increased their holding to 4% of the Company as seen on the TR1 of 15th July 2020.

Furthermore, Intrinsic have Just lobbed in £250K at 10p a share To be followed by a further £1.75M at 10p by the end of this month.

(Followed by a further £7.7M at predetermined dates)

They aren’t putting in this sort of cash on a whim & with this sort of support I don’t see other benchmark investors selling down just as the snowball is about to start rolling.

What price attracts the buyers again.

8p plus a 20% Buying flurry of activity Puts us back at 9.6p.

Any Chartists out there?

So NFX with NXP002 is at a similar stage at REDX RXC006 With clinical trials of its Fibrosis treatment beginning in 2021.

Furthermore, NXP001 has passed Clinical trials & is ready to out licence.

NFX sits with It’s lowly SP, And on announcement of a deal we can see the values attributed to these sorts of drugs.

With AstraZeneca taking a position with REDX let’s see who’s sniffing around NFX!!!

I’m buying more here!!!

Uuuuum, up 13.7%, please see my earlier post.

Will catch on to the potential here, & the fact that 002 is on the cusp of realising value.

Investors are Currently focussed on Covid vaccines but not dealing with the medication to help mitigate the damage caused.

I sense very little available stock hence upward movement on Zilch & the fact the MM’s will take the lot at over......

From the 22nd July.

Far more measured & less ‘excitable’ than DG.

NXP002

‘Not necessarily a net negative....we do have assets that have the potential to treat Covid 19, something we have tried to take advantage of in both our ongoing & our future negotiations.....’

Our ‘Asian’ negotiations have been ‘ongoing’ and an agreement could Be announced anytime.
The future negotiations refer to ROW rights.

Personally, I’m glad this guy is in charge now, I get a real sense of a proper strategy in place & with competent negotiators At our table.

‘Larger, medium term revenues....’

I like that sound of that.

Most fund raises for large holdings for Institutional Investors are made at hefty discounts.

These usually arrive just when a stock starts to make momentum, the raise arrives and pegs the SP back for a few months whilst the stock consolidates.

In this case we have a II taking a big chunk in excess of the current SP.

Not only that, the warrants are way out at 25p.

Dev is going to be very well funded as it continues to roll out, we may well make some acquisitions too.

It’s a great place to be for any investor, with a few major contracts in the bag & access to plenty of cash.

Intrinsic must really like what they see.

Intrinsic have bought 2.5M Shares at 10p, £250K’s Worth.

By the end of August they’ll also plop in a further £1.75M at 10p a share.

They sound very amenable, DEV has altered the terms to release £250K without providing the Prospectus, and ICJ are still buying at 10p.

Business that is currently being rolled out across the globe By a monster Company.

We have a Institutional Investor coming aboard for £10M at 10p a share, with an option for 50M warrants are 25p.

Today’s report is historic, the market looks forward & today will be used by the savvy to pick up even more cheap stock.

Going on about the effects of Covid, and lung damage, particularly IPF.

It was an order that was filled over the past days, that’s why the price was walked down To nearly 8p...... there’s very limited Freefloat now & anyone wanting £180K’s worth of shares is going to be paying a decent premium.

I wonder if Mr Vanderlip has accumulated further.

We’ll find out next week.

Hence no trades for 20 mins.

They’ll have to raise it sharpish to find any sellers.

Incoming I suspect, the freefloat continues to diminish.

It’s interesting that as the World starts speculating on a second wave, momentum continues to build in the Edtech sector, fast forwarding the inevitable rollout of the future in Education.

This is a very interesting little Company, that’s going to get quite a lot bigger in a short space of time.

Remains that 002 could be very valuable.

The Company has been very careful to adhere very strictly to their Confidential discussions, since the leak last year probably almost scuppered the deal.

No-one will know the value of any deal until it is announced to the market.

No more Podcasts. No chit chat.

Just wham.

And if you’re not holding, you won’t get a look in.

Quickly now.

210 going

Yup, very hard work adding.....

Going through as sells at 10.055p.